Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Bismuth Quadruple Therapy for H. pylori
NCT03156855Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Primary endpoint: Eradication rate at 6 weeks. Status: unknown.
02
Drugs
esomeprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03156855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156855.